Cargando…
Exploring brusatol as a new anti-pancreatic cancer adjuvant: biological evaluation and mechanistic studies
Pancreatic cancer is highly resistant to chemotherapeutic agents and is known to have a poor prognosis. The development of new therapeutic entities is badly needed for this deadly malignancy. In this study, we demonstrated for the first time that brusatol, a natural quassinoid isolated from a Chines...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689587/ https://www.ncbi.nlm.nih.gov/pubmed/29156697 http://dx.doi.org/10.18632/oncotarget.17761 |